ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2332

Cardiovascular Risk Factors in Rheumatoid Arthritis: Prevalence, Comparison of Risk Calculators and Subclinical Atherosclerosis in Indian Patients

Hafis Muhammed1, Durga P Misra 1, Sujata Ganguly 1, Sarit Sekhar Pattanaik 1, Saurabh Chaturvedi 1, Harshit Singh 1, Mohit K Rai 1, Anamika Anuja 1, Namita Mohindra 1, Neeraj Jain 1, Sudeep Kumar 1 and Vikas Agarwal 1, 1SGPGI, Lucknow, Uttar Pradesh, India

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cardiovascular disease, Comorbidity, diabetes and hypertension, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis(RA) patients have increased cardiovascular(CV) risk with no data on CV risk scores in Indian patients.The primary objective was to study prevalence of traditional CV risk factors in RA. Secondary objectives were to assess performances of various CV risk scores with respect to each other and against subclinical atherosclerosis as measured by carotid intima media thickness(CIMT).

Methods: Patients fulfilling 2010 ACR/EULAR criteria for RA were included. Presence of traditional CV risk factors were recorded. 10-year-CV risks were predicted using Framingham Risk scoring using lipids (FRS-Lipids) and body mass index (FRS- BMI), QRISK-3, SCORE and the algorithm recommended by 2013-ACC/AHA guidelines(ASCVD) in patients who were 40 years or older. CIMT was measured on the far-wall of the common carotid artery at least 5 mm below its end.  CIMT value greater than 0.90 mm or presence of plaque was chosen as marker of subclinical atherosclerosis.

Results: Table 1 highlights clinical profile and risk factors in 334 enrolled patients. Friedman’s test for global variance of various showed significant difference among various risk predicting algorithms. Post-hoc analysis done with Wilcoxon-signed-rank test showed significant variability between each of them. When subclinical atherosclerosis assessed by CIMT was taken as reference, ASCVD and QRISK-3 showed maximum sensitivity Fig:1. Differences in disease characteristics and risk factors between patients with and without subclinical atherosclerosis and are underlined in Table 2.

Conclusion: There is considerable variablity between various risk scores and cannot be used indiscriminately in Indian RA patients. ASCVD and QRISK-3 scores had the maximum sensitivity in predicting subclinical atherosclerosis.

Table1. Demographics, Disease characteristics and prevalence of Traditional risk factors

Table2. Comparison between patients with and without subclinical atherosclerosis

Fig1: ROC for various risk scores in predicting subclinical atherosclerosis


Disclosure: H. Muhammed, None; D. Misra, None; S. Ganguly, None; S. Pattanaik, None; S. Chaturvedi, None; H. Singh, None; M. Rai, None; A. Anuja, None; N. Mohindra, None; N. Jain, None; S. Kumar, None; V. Agarwal, None.

To cite this abstract in AMA style:

Muhammed H, Misra D, Ganguly S, Pattanaik S, Chaturvedi S, Singh H, Rai M, Anuja A, Mohindra N, Jain N, Kumar S, Agarwal V. Cardiovascular Risk Factors in Rheumatoid Arthritis: Prevalence, Comparison of Risk Calculators and Subclinical Atherosclerosis in Indian Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-risk-factors-in-rheumatoid-arthritis-prevalence-comparison-of-risk-calculators-and-subclinical-atherosclerosis-in-indian-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-risk-factors-in-rheumatoid-arthritis-prevalence-comparison-of-risk-calculators-and-subclinical-atherosclerosis-in-indian-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology